Loading...
DaVita Inc.
DVA•NYSE
HealthcareMedical - Care Facilities
$137.88
$0.14(0.10%)
DaVita Inc. (DVA) Financial Performance & Statements
Review DaVita Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
5.56%
↑ 5.56%
Operating Income Growth
30.43%
↑ 30.43%
Net Income Growth
35.40%
↑ 35.40%
Operating Cash Flow Growth
-1.80%
↓ 1.80%
Operating Margin
15.77%
↑ 15.77%
Gross Margin
32.46%
↑ 32.46%
Net Profit Margin
6.63%
↑ 6.63%
ROE
393.58%
↑ 393.58%
ROIC
14.39%
↑ 14.39%
DaVita Inc. (DVA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for DaVita Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.29B | $3.26B | $3.19B | $3.07B |
| Cost of Revenue | $2.23B | $2.15B | $2.32B | $2.08B |
| Gross Profit | $1.07B | $1.11B | $868.76M | $991.58M |
| Gross Profit Ratio | $0.32 | $0.34 | $0.27 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $414.48M | $393.53M | $367.85M | $362.48M |
| Operating Expenses | $503.95M | $576.84M | $367.85M | $549.56M |
| Total Costs & Expenses | $2.73B | $2.73B | $2.69B | $2.63B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $138.72M | $134.58M | $97.75M | $99.42M |
| Depreciation & Amortization | $174.10M | $187.01M | $175.66M | $187.08M |
| EBITDA | $729.06M | $697.52M | $691.88M | $629.10M |
| EBITDA Ratio | $0.22 | $0.21 | $0.22 | $0.20 |
| Operating Income | $565.36M | $534.88M | $500.92M | $483.85M |
| Operating Income Ratio | $0.17 | $0.16 | $0.16 | $0.16 |
| Other Income/Expenses (Net) | -$151.63M | -$161.44M | -$134.96M | -$112.06M |
| Income Before Tax | $413.73M | $373.43M | $371.44M | $371.79M |
| Income Before Tax Ratio | $0.13 | $0.11 | $0.12 | $0.12 |
| Income Tax Expense | $64.49M | $77.67M | $71.69M | $65.81M |
| Net Income | $259.33M | $214.69M | $222.68M | $239.65M |
| Net Income Ratio | $0.08 | $0.07 | $0.07 | $0.08 |
| EPS | $3.18 | $2.56 | $2.56 | $2.73 |
| Diluted EPS | $3.02 | $2.50 | $2.50 | $2.65 |
| Weighted Avg Shares Outstanding | $81.62M | $83.72M | $86.90M | $87.78M |
| Weighted Avg Shares Outstanding (Diluted) | $85.80M | $85.80M | $88.95M | $90.55M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan